- Study Protocol
- Open access
- Published:
The feasibility and acceptability of an online mindfulness-based stress reduction program for chronic musculoskeletal pain: protocol for a pilot randomised controlled trial
Pilot and Feasibility Studies volume 11, Article number: 30 (2025)
Abstract
Background
Chronic musculoskeletal pain conditions affect millions of people worldwide and place a significant burden on individuals and the healthcare systems. Managing chronic musculoskeletal pain requires a multidisciplinary approach that considers biological, psychological, and social factors. However, access to multidisciplinary pain care is challenging, and long wait times can lead to increased stress and health deterioration. Mindfulness-based stress reduction (MBSR) is a mind-body approach developed specifically to reduce the distress of living with chronic conditions, such as chronic musculoskeletal pain. This study proposed a novel approach by offering an online MBSR program to patients on waitlists to attend a multidisciplinary pain clinic in Australia’s public healthcare system that could improve health outcomes. The study aims to assess the feasibility, acceptability, and potential efficacy of this approach using a pilot study design with a mixed-methods approach.
Methods
This is a mixed-methods pilot randomised controlled trial with an embedded qualitative study. Participants will be recruited from waitlists at two multidisciplinary pain management centres within the Sydney Local Health District in New South Wales, Australia. This pilot trial will randomly assign 32 individuals with chronic musculoskeletal pain to either an online MBSR group or a usual care control group. Feasibility outcomes, patient-reported outcomes, adherence to mindfulness practice, and adverse events will be assessed using validated questionnaires. Semi-structured interviews will be conducted with participants in the MBSR group to explore their experiences and evaluate acceptability, and barriers and facilitators of engagement with the intervention.
Discussion
This pilot study will evaluate a novel approach to integrating MBSR into the Australian public healthcare system as a mechanism for providing support to individuals with chronic musculoskeletal pain who are waitlisted for a multidisciplinary pain management program. Findings from this study will indicate the feasibility, acceptability, safety, and preliminary efficacy of this approach in terms of patient-reported outcomes to guide the design of future large-scale clinical trials.
Trial registration
This trial was prospectively registered in the Australian New Zealand Clinical Trials Registry (ACTRN12622000822785).
Background
Chronic musculoskeletal pain is a significant public health problem affecting millions worldwide [1], causing widespread suffering for individuals and substantial costs for society [2]. The 2019 Global Burden of Disease (GBD) report illustrates the staggering scale of this problem, reporting that over 1.7 billion individuals worldwide are living with musculoskeletal pain, including neck and lower back pain [3]. Musculoskeletal pain conditions collectively contribute to 149 million years lived with disability (YLD), constituting nearly 17% of the global disease burden. This ranks musculoskeletal pain as the predominant YLD contributor on a global scale [3]. In Australia alone, the financial cost of chronic musculoskeletal pain is estimated at $55 billion annually, incorporating healthcare utilisation, lost productivity, carer burden, and reduced quality of life [4, 5]. Despite treatment advances [6, 7], the prevalence and burden of chronic musculoskeletal pain have increased over time [8], and are expected to continue to increase over the coming decades [9, 10].
Chronic musculoskeletal pain is well-recognised as a multifaceted condition, characterised by a complex interplay of biological, psychological, and social factors, making it challenging to manage [11]. Individuals living with chronic musculoskeletal pain often report high levels of pain-related emotional distress [12,13,14]. Best practice guidelines recommend integrating physical and psychological interventions for managing chronic pain, often delivered by a multidisciplinary team [15]. This model is an established standard of care provided in public tertiary pain management centres in Australia and is based on specialised assessment and treatment processes, including a multidisciplinary team approach and group pain management programs [16]. However, wait times to access such services often far exceed the recommended 6-month maximum wait, with the most disadvantaged individuals experiencing up to 3 years in the waitlist [17]. Long delays in access to treatment can exacerbate distress and, consequently, physical and psychological deterioration [18]. While system-level strategies are required to reduce waitlist times, we can develop strategies to mitigate the distress and potentially improve the outcomes of patients who are on waitlists.
Mindfulness-based stress reduction (MBSR) is a mind-body training program developed specifically to address the distress associated with long-term conditions, such as chronic pain [19]. The MBSR program combines mindfulness meditation, body awareness, yoga, and exploration of patterns of behaviour, thinking, feeling and action [20]. By engaging participants holistically on multiple levels (i.e. physiological and emotional regulation, cognitive reappraisal, behavioural change, engagement with values, and social connection), MBSR has been shown to significantly reduce pain [21, 22], improve symptoms of anxiety, and depression and improve quality of life, in people with various chronic conditions [23], including chronic musculoskeletal pain [22,23,24]. MBSR is typically delivered as a face-to-face, 8-week program, with weekly 2.5-h group sessions, and an expectation of daily practice by participants [20]. However, recent evidence has shown that online delivery of MBSR is comparably effective to in-person delivery [25]. An online delivery mode allows participants to complete the program without the need to travel to a single location, which can pose logistical and financial challenges [26].
Despite evidence supporting the efficacy of MBSR in improving patient-reported outcomes for chronic pain [21], availability to patients in Australia remains limited. MBSR programs are primarily offered as privately funded courses, which are costly thereby excluding a large proportion of patients with chronic musculoskeletal who cannot afford it [27]. Addressing this barrier to access calls for the incorporation of MBSR programs into the public health system [28]. This shift could improve access to a mind-body approach that can improve the well-being of patients with chronic musculoskeletal pain, thereby mitigating health inequities. However, implementing a novel intervention in health services requires significant and planned changes, and the first step is to test its practicality [29]. In this context, pilot studies play a crucial role in testing and refining the research methods and procedures prior to a fully powered clinical trial. Pilot trials further assist in identifying potential barriers and facilitators related to the intervention, enable assessment of the feasibility of data collection and analysis, and by uncovering any issues early on, guide necessary adjustments that improve the quality and efficiency of fully powered clinical trials [30].
Our study, therefore, aims to (1) evaluate the feasibility of an online MBSR program for managing chronic musculoskeletal pain within the public health care system in Australia; (2) identify barriers and facilitators related to the online MBSR program for people with chronic musculoskeletal pain; and (3) determine the preliminary efficacy and safety of the online MBSR program compared to usual care on patient-reported outcomes.
Methods
Study design
This is a pilot randomised controlled trial (RCT) with an embedded qualitative study. We will follow the first two steps in the Sax Institute’s Translational Research Framework [31] to investigate the feasibility and preliminary efficacy of an online MBSR program for chronic musculoskeletal pain. This Translational Research Framework serves to bridge the gap between research and real-world implementation by systematically addressing barriers at different stages of translation. This study specifically focuses on two key translational steps: (1) T1 (feasibility testing): assessing the feasibility of the intervention in a controlled setting, including recruitment, adherence, and preliminary engagement outcomes; and (2) T2 (clinical research): assessing the preliminary efficacy of the intervention to determine its potential benefits. These steps provide a structured approach to evaluating the feasibility and preliminary efficacy of the online MBSR program for individuals with chronic musculoskeletal pain [32].
This study employs an exploratory sequential mixed-methods design, in which quantitative data will be collected first, followed by qualitative interviews to provide further insights into participants’ experiences. This approach enables the identification of key trends in the quantitative data, which can then be explored in greater depth through qualitative methods. The quantitative component will assess recruitment rates, intervention adherence, patient-reported outcomes, and adverse events, providing objective feasibility data. The qualitative component, gathered through semi-structured interviews, will explore participants’ experiences with the program, including barriers and facilitators to engagement, intervention acceptability (e.g. content, complexity, delivery, and areas for improvement), and key factors influencing future implementation and scalability. This integrated approach ensures a comprehensive evaluation of both feasibility and user experience, informing the design of a larger-scale trial. To ensure clarity and transparency in reporting, study findings will adhere to the CONSORT 2010 statement: extension to randomised pilot and feasibility trials [33]. The qualitative component will be reported following the Consolidated Criteria for Reporting Qualitative Research (COREQ): a 32-item checklist for interviews and focus groups [34].
Participants’ inclusion and exclusion criteria
Pilot RCT
A total of 32 individuals with chronic musculoskeletal pain will be randomised to either an online MBSR group (n = 16) or a usual care control group (n= 16). This sample size has been determined based on feasibility considerations and recommendations for pilot studies. A detailed justification is provided in the Sample Size section (page 16). We will include people that (i) are 18 years or older; (ii) have chronic primary or secondary musculoskeletal pain as described by the IASP (International Association for the Study of Pain) classification of chronic pain for ICD-11 (i.e. “pain located in the muscles, bones, joints, or tendons”) [35]; (iii) are proficient in English (i.e. able to read and understand the consent form, participant information sheet, and study materials without the need for assistance from a translator); (iv) are able to access the internet via a computer (desktop or laptop) or a smartphone. We will exclude people who (i) have pain from serious pathologies such as fractures or cancer; (ii) have self-reported active or uncontrolled mental illness (i.e. severe depression, active suicidality, bipolar disorder, and schizophrenia that is not managed by a health care professional—psychologist, psychotherapist, psychiatrist); (iii) have a history of an unexplored, untreated traumatic experience or adverse childhood events assessed by an experienced clinician during the telephone screening process; or (iv) are judged at the investigator’s discretion as being unsuitable to participate (e.g. inability or unwillingness to attend the weekly group sessions).
Qualitative study
Participants from the intervention group (MBSR group) participating in the pilot RCT will also be invited to participate in the embedded qualitative study, which will use in-depth semi-structured interviews to explore the participant’s experience in the MBSR program. We will strive to recruit a diverse sample of participants covering a broad population, including people from varied occupation status and cultural backgrounds, age groups, and genders.
Recruitment
Pilot RCT
Pre-screening
We will recruit individuals with chronic musculoskeletal pain who are on the waitlist to receive care at the pain management centres at Royal Prince Alfred Hospital (RPAH) and the Concord Repatriation General Hospital (CRGH) in the Sydney Local Health District (SLHD) in Sydney, New South Wales (NSW), Australia. The average time spent on the waiting list to access the Pain Management Centre at RPAH and CRGH varies from 6 to 12 months.
The Clinical Nurse Consultants at the RPAH and CRGH pain management centres will call individuals on the waitlists and inform them about the study. They have received training in describing the study and answering questions related to the study protocol from the Coordinating Principal Investigator. The Clinical Nurse Consultants have also been provided with a script to use during the telephone calls. If individuals are interested in learning more about the study, the Clinical Nurse Consultants will ask permission to (a) share their name and contact information with the research team; and (b) send them an email containing a study advertisement and a Participant Information Sheet that describes the study’s eligibility pre-screening process. The recruitment email also contains a link that will take them to a pre-screening Consent Form and a short pre-screener survey created with the Research Electronic Data Capture (REDCap), which will contain some questions regarding their eligibility for joining the study. Where permission is given, after each phone call, the Clinical Nurse Consultants will share the name, phone number and email address of the interested potential participants with the research team, via a form on REDCap.
If a potential participant does not answer the Clinical Nurse Consultant’s phone call, they will be sent an SMS that will inform them about the study. The SMS will contain a URL link that will take them to an online copy of the Participant Information Sheet, the pre-screening Consent Form, and the short pre-screener survey. The SMS will be sent using a programmable messaging API (Application Programming Interface) from Twilio that is integrated with REDCap. Potential participants can reply ‘STOP’ to the SMS to opt out of any future communications about the study.
Potential participants who expressed interest in the study over the phone with one of the Clinical Nurse Consultants who did not complete the pre-screener survey will be sent a reminder email 3 to 5 days after the initial email. The reminder email will also mention that a research investigator may contact potential participants on their provided phone number to see if they have received this email and if they are still interested in learning more about the study.
If potential participants do not complete the pre-screener survey after the reminder email, a research investigator will call them 1 week after the initial contact from the Clinical Nurse Consultants to ask if they have received the email and if they are still interested in learning more about the study. This will be the last attempt to contact the participants. No further contact will be made if they are not interested. During the call, if they remain interested in the study, the research investigator will direct the potential participants to the email or re-send the email with the Participant Information Sheet, Consent Form and the pre-screener survey. Potential participants will also have the opportunity to ask questions about the study during the phone call.
If a potential participant who received a recruitment SMS and did not opt out of future communications about the study does not complete the pre-screener survey, they will be sent a follow-up SMS 5 days after the initial SMS. This will be the last attempt to contact the participants. No further contact will be made if they are not interested.
If eligible after completing the pre-screener survey, potential participants will receive a phone call from an experienced MBSR teacher and psychotherapist to screen for mental health concerns. During the phone call, the MBSR teacher will ask eleven questions to screen for any severe and uncontrolled mental health condition or a history of an unexplored, untreated traumatic experience. If eligible after completing the mental health screen, potential participants will be reminded that if they agree to participate in the study, they have a 50% chance of being in either the MBSR group or the usual care control group.
Participants in the usual care group will continue to receive the care that patients usually receive while they are on the waitlist to attend the pain management centres at the RPAH and CRGH. Potential participants will also be asked their preferred day and time to attend the weekly 2.5-h MBSR group sessions, in case they agree to enrol in the study and are allocated to the MBSR group. If ineligible, individuals will be provided with the reason why they are not eligible for the study. All ineligible individuals will be given the contact details of the Coordinating Principal Investigator, who can clarify any questions they may have. They will be informed they will remain on the waitlist to receive care at the RPAH or the CRGH pain management centres. If individuals are distressed because they are ineligible for the study, they will be referred to the Pain Specialist and Site Principal Investigator from the relevant Pain Management Centre, or if unavailable, the relevant Clinical Nurse Consultant, for support. If necessary, the Clinical Nurse Consultant will refer the participant to the Clinical Psychologist available on the day.
Enrolment
Potential participants who are deemed eligible to join the pilot RCT after the pre-screening process, and who indicate an interest in participating in the pilot RCT, will be sent the pilot RCT Participant Information Sheet via email to keep. Potential participants can take their time to think and decide. If they agree to join the RCT, they will be asked to sign a consent form embedded into REDCap. A link to the consent form will be sent via email. Potential participants who do not complete the electronic consent form will be sent a follow-up email 3 to 5 days after the initial email. The reminder email will also mention that a research investigator may contact potential participants on their provided phone number to check receipt of this email and confirm that they are still interested in participating in the study. If a potential participant does not complete the electronic consent form after the follow-up email, a research investigator will call them 1 week after the initial email to determine whether they have received the email and whether they are still interested in participating in the study. This will be the last attempt to contact the participants. The screening process is illustrated in the screening flowchart (Fig. 1). Should participants volunteer, the research investigator will emphasise that they are free to withdraw from the study at any time without penalty.
Group allocation
After eligibility is confirmed, participants will be randomly assigned to either the online MBSR intervention or the control group using a computer-generated randomisation sequence with a 1:1 allocation ratio. An independent researcher not involved in recruitment will generate the randomisation sequence to minimise bias. Randomisation will occur after baseline data collection to prevent allocation bias.
Qualitative study
All participants completing the MBSR program as part of the pilot RCT will be purposively invited for in-depth interviews after completing the program. Research investigators will contact MBSR program participants to invite them to take part in the interviews after the program is finished. Potential participants interested in participating in the interviews will receive the Participant Information Sheet and Consent Form via email.
Intervention
-
(1)
Participants will be randomised into one of two parallel groups: (1) an online live facilitated MBSR group or (2) a usual care control group.Participants in the online live facilitated MBSR group will participate in an 8-week intervention involving weekly 2.5-h online group sessions and one online half-day workshop. This 6-h workshop, called “The Day of Mindfulness”, will be scheduled between the sixth and seventh week, and is held in silence with only the instructor speaking. This “retreat” will provide participants with an opportunity to deepen what they learn during the weekly online sessions. Participants will be encouraged to practice mindfulness daily throughout the 8-week period. In addition, participants will receive access to a 100-page coursebook, and a mobile application called Openground Mindfulness Training which has pre-recorded guided meditation practices that participants can use throughout the program. Patient data and app usage data will not be sent to the mobile application developer. Participants will also receive ongoing individual support from the MBSR teacher, as necessary.
Mindfulness is defined as non-reactive awareness of the present experience, including body sensations, internal mental states, thoughts, emotions, impulses and memories [20]. Mindfulness meditation is a mind training approach that cultivates cognitive control, emotion regulation and acceptance (i.e. nonreactivity), which leads to reduced stress and increased well-being [20]. During the online MBSR program, participants will meet once a week for 2.5 h via an online platform to practice mindfulness meditation and body awareness. During this time, the participants will also interact with each other through discussions facilitated by a skilled, certified MBSR teacher. Our proposed mindfulness intervention is based on MBSR, but it has been adapted for individuals with chronic pain. This program integrates psychoeducation on the latest pain neuroscience based on the evidence-based Explain Pain program [36, 37]. Each week, the teacher presents the theoretical underpinnings of the mindfulness training and the application of self-regulatory skills and encourages dialogue and reflection on distinct topics as described in Table 1 below.
-
(2)
Participants in the usual care control group will receive the type of care that is usually provided to individuals who are on the waitlist to attend the pain management centres at the RPAH and CRGH. This care often includes accessing brief pain education. This may be accessed through the STEPS program at the RPAH, the DIB program at the CRGH, or through My Pain Hub, a passive online evidence-based resource for musculoskeletal pain. Participants in this group will also be offered access to a passive online evidence-based educational resource for musculoskeletal pain developed by our team My Pain Hub (https://www.mypainhub.com). MyPainHub has been co-designed and developed by clinicians managing and people with musculoskeletal pain and tested in a recent RCT [38]. The patient pages contain accurate advice, information, and self-directed exercises for common musculoskeletal conditions.
Outcome measures
Pilot RCT
Feasibility outcomes
Feasibility outcomes will include recruitment rate, retention rate, suitability of data collection methods, and identification of successful recruitment methods. Records will be kept of the number of individuals screened for eligibility, the number eligible and invited to participate, and the number that consent to participate. We will also record reasons for not entering the study and reasons for dropping out. Our pilot trial will be deemed feasible if at least 80% of the participants recruited for our pilot trial remain in the study until its completion. Our progression criteria for the trial will follow the traffic light system proposed by Avery and colleagues [39], where achieving green (go)—80% retention rate—indicates that the criteria have been met, and the trial should proceed, achieving amber (amend)—60% retention rate—indicates that some changes should be made to the larger trial and achieving red (stop)—40% retention rate—indicates that the investigators should not move forward with the larger trial. To keep a record of the issues faced during the pilot trial, we will maintain a document called ‘lessons learned’ that details the problems encountered, the attempts made to resolve them, and whether they worked or not [40].
Patient-reported outcome measures (PROMs)
Upon entry to the study, prior to randomisation, we will collect demographic information, including age, gender, race, ethnicity, education level, and postcode (to be used as a proxy for socioeconomic status). We will also collect information about the participant’s general health status and pain condition, including the number of years they have lived with chronic pain and their primary sources or locations of pain. Patient-reported outcome measures will be collected upon entry to the study prior to randomisation, and at the conclusion of the online MBSR program, to assess preliminary pre- to post-intervention changes. We will use the validated and widely used patient-reported outcome measures that make up the electronic Persistent Pain Outcomes Collaboration (ePPOC). The ePPOC is a resource for pain researchers and clinicians, which was established in NSW in 2013, to evaluate and assist in improving outcomes and services for people experiencing chronic pain [41]. The ePPOC measures pain and disability using the Brief Pain Inventory (BPI) [42], cognition using the Pain Self-Efficacy Questionnaire (PSEQ) [43], pain catastrophising using the Pain Catastrophising Scale (PCS) [44], mood using the Depression, Anxiety and Stress Scale (DASS-21) [45], health care utilisation and medication. These measures are recommended and used in pain management centres within Australia and New Zealand. We will also measure chronic pain acceptance using the Chronic Pain Acceptance Questionnaire (CPAQ) [46]. The CPAQ measures two aspects of chronic pain acceptance - activity engagement and pain willingness. Participants will be emailed a link to these questionnaires, which will be embedded into a web-based application (REDCap). The data collection process is illustrated in Fig. 2.
Adherence to the mindfulness practice
Adherence to the suggested daily mindfulness practices throughout the 8-week intervention will be measured weekly via REDCap, using an online version of the Mindfulness Adherence Questionnaire (MAQ) [47]. The MAQ is a 12-item self-reported questionnaire that captures adherence to the mindfulness practice within the past week. It was designed to assess regular and sustained practice in attentional focus and non-judgmental acceptance (i.e. quantity, quality, subtype of practice). The first two items measure the frequency and average duration (in minutes) of formal practices. The remaining 10 items measure the quality of formal practice and informal practice. Items are scored on a 7-point Likert scale ranging from 0 (never) to 6 (always), with higher total subscale scores reflecting higher practice quality.
Adverse events
The Meditation-Related Adverse Effects Scale - Mindfulness-Based Program version (MRAES-MBP) [48], will be used to collect data regarding adverse events. An email with a link to the MRAES-MBP embedded in REDCap will be sent to participants weekly. The MRAES-MBP scale represents the ten most common adverse events and those most highly associated with negative impacts on functioning, in the context of a mindfulness-based program, specifically: signs of hyperarousal (anxiety, perceptual hypersensitivity, traumatic re-experiencing, emotional lability, insomnia), hypo-arousal/blunting (anhedonia, depersonalisation), executive dysfunction and social disengagement [48]. If a participant reports experiencing distress that is impairing their ability to function, they will receive a phone call from our MBSR program teacher, who is an experienced Medical Doctor with extended skills in psychological medicine and a special interest in mindfulness-based interventions, complex trauma and the psychological aspects of chronic pain. Depending on the severity of the distress and the level of impact on functioning, the meditation practices may need to be adjusted or discontinued, or the participant may be advised to discontinue the intervention altogether. Where appropriate, the participant will be referred to the psychologist at the RPAH or CRGH pain management centres.
Qualitative study
Acceptability, and barriers and facilitators of engagement
Qualitative data, collected through in-depth interviews, will explore participants’ experiences with the MBSR program, focusing on barriers and facilitators to engagement and the acceptability of the intervention. Qualitative research is essential for capturing the lived experiences of participants, offering insights that quantitative measures alone cannot provide. By examining participants’ perspectives, we can identify key factors influencing participation, refine the intervention to enhance accessibility and adherence, and inform future implementation strategies [34]. The investigators conducting these in-depth interviews will be independent from the MBSR program. Additionally, the interviewees will not know the investigators conducting these in-depth interviews. All interviews will be audio-recorded and transcribed verbatim.
Sample size
Pilot RCT
Decisions about sample size in pilot studies can be challenging as a variety of approaches exist [49,50,51,52]. Some researchers suggest that pilot studies should include at least 30 participants to provide a reliable estimate of the standard deviation, which is essential for calculating the sample size of a future full-scale trial [51]. Based on these guidelines, we plan to recruit 32 participants (approximately 16 per group) for this pilot study. This represents 9% of the estimated sample size for the full trial, which is the minimum threshold recommended by Cocks and Torgerson (2013) [50]. This sample size provides >80% confidence in determining whether to proceed with a full trial, aligning with feasibility objectives. The calculation is based on an estimated effect size difference for the full trial, using a confidence interval approach [50]. A key feasibility outcome is the retention rate, which we anticipate to be 80%. Given our sample size (N= 32), this can be estimated to be within approximately ±15% with 95% confidence, meaning that around 26 participants are expected to complete the study [39]. However, we acknowledge that this estimate is provisional and will be refined based on feasibility data collected from the pilot study, including actual retention rates, standard deviation estimates, and adherence metrics.
Qualitative study
In qualitative research, the sample size needs to enable rich and diverse data to be collected to provide valuable insights about the topic of interest and to be sufficient to generate an in-depth understanding of it [53]. Based on this information, we have estimated that around 12 to 15 participants may be necessary to reach the qualitative purposes of this study.
Data analysis
Pilot RCT
Baseline demographics will be described using means and percentages and their standard deviations. Primary feasibility outcomes will be analysed using percentages (proportions) and 95% confidence intervals (CIs). Patient-reported outcome measures—including physical function, anxiety, depression, fatigue, sleep disturbance, ability to participate in social roles and activities, pain interference, pain intensity, chronic pain acceptance and mindfulness adherence—will be analysed using between-group comparisons based on intention-to-treat principles Given the exploratory nature of this pilot study, we will report mean differences with 95% confidence intervals to describe potential trends and variability in the data. Quantitative analysis will focus on estimating effect sizes and variability, which will help guide the design and sample size calculation of a future full-scale trial. This approach aligns with best practices for pilot studies, ensuring that the findings are used primarily to inform the feasibility and refinement of the intervention [54].
Qualitative study
Qualitative interview data will be analysed using reflexive thematic analysis [55], with the assistance of NVivo software. The Coordinating Principal Investigator and the interviewer will jointly conduct the thematic analysis of the transcripts supervised by an experienced qualitative researcher. Contextual themes will be identified in the data and supported by quotes. All members of the research team will provide input into the results and will be encouraged to engage in reflexivity as part of the analytical process (i.e. reflect on their reactions to the data, how their positionality may influence their interpretation, their motivations to engage in such research, and more). Rigour will be guided by Braun and Clarke’s recommendations for reflexive thematic analysis [55]. The qualitative findings will be integrated with the quantitative results to provide a richer understanding of feasibility outcomes, such as adherence rates and participant-reported experiences. Thematic analysis of the qualitative data will be conducted after quantitative analysis, allowing for triangulation of findings and identification of factors that may influence intervention engagement and effectiveness [55].
Ethics
This pilot RCT includes key methodological features to minimise bias in clinical trials, such as randomisation, concealed allocation, specification of eligibility criteria, blinded outcome assessment, blinded analysis, and intention-to-treat analysis. Data will be stored in spreadsheets and transferred to appropriate statistical software for analysis by an investigator blinded to group allocation. Spreadsheets will be regularly scrutinised for omissions and errors. Data will be stored and accessed as per the ethics requirements.
We will adhere to the Australian Code for the Responsible Conduct of Research for the storage and archiving of data. Data will be retained for 5 years with restricted access (the research data and/or metadata cannot be shared). All data files (e.g. audiotapes, transcripts) will be stored on a secure server at The University of Sydney, with access restricted to the study investigators. Data files will be coded. After 5 years of storage, the data will be securely destroyed. Electronic data will be deleted, and any paper copies will be shredded.
A Data Safety Monitoring Board (DSMB) will be convened to oversee this study. The board will be comprised of three members: an Associate Professor who is a psychologist, an Associate Professor who is a physician, and a senior physiotherapist who is the Director of Allied Health Services at one of the Sydney Local Health Districts and Co-Chair of the Musculoskeletal Network at the Agency of Clinical Innovation. The DSMB will have an initial meeting before the study commences. In this initial meeting, the DSMB will review the role and functioning of the DSMB, discuss the format and content of the DSMB reports and review scientific and ethical issues relating to the design and conduct of the trial. The DSMB will meet again at 4 weeks after the MBSR program commences and at the end of the 8-week program.
Discussion
Chronic musculoskeletal pain is a global health challenge that causes a significant burden to individuals and society [1]. Despite continuous advancements in treatment approaches, the prevalence and impact of chronic musculoskeletal pain continue to rise, making it a public health priority [1]. This pilot study lays the groundwork for assessing the feasibility, acceptability, and potential efficacy of integrating an online MBSR program into the Australian public healthcare system, thereby offering hope for a more equitable approach to managing this highly prevalent condition. Despite the evidence supporting MBSR’s efficacy for chronic pain [21], MBSR remains largely inaccessible to patients with chronic musculoskeletal pain conditions within the Australian public healthcare system. Current MBSR programs in Australia are predominantly offered as private courses, often associated with high costs, thus excluding a substantial portion of patients.
Online MBSR programs have become a convenient and accessible alternative to traditional in-person training [25]. Our study will explore the feasibility of offering an online MBSR program to individuals on the waitlists of two pain management centres at two major metropolitan hospitals in Sydney, NSW, Australia. Our feasibility outcomes, such as our recruitment and retention rates, will explore participants’ willingness to engage with this mind-body approach. Our findings will also demonstrate which individuals with chronic musculoskeletal pain are receptive to online interventions and are willing to explore new avenues for pain management. While the primary focus of this pilot study is feasibility and acceptability, preliminary efficacy regarding patient-reported outcomes, including pain, disability, mood, self-efficacy, pain catastrophising, and quality of life, will also provide valuable insights. While the results of the patient-reported outcomes should be interpreted with caution due to the small sample size and the preliminary nature of this study, this process will be insightful as it will demonstrate the feasibility of our data collection methods. Our skilled MBSR teacher will be able to guide participants through potential challenges and ensure their safety and well-being during the program. Nevertheless, adverse events will be monitored closely, addressing a gap in the literature regarding the reporting of adverse events in mindfulness trials.
The qualitative component of this study will provide valuable insights into participants’ experiences, identifying both barriers and facilitators to engaging with the MBSR program. Understanding these factors is critical for refining the online intervention and optimising its acceptability and delivery in future trials and, ultimately, within the healthcare system.
This pilot study will serve as a foundation for potential future research that integrates MBSR into health services. Building on the lessons learned and insights gained from this study, a fully powered clinical trial may be designed and implemented, with a more extensive and diverse participant pool, to provide robust evidence regarding the effectiveness of online MBSR for chronic musculoskeletal pain in the Australian healthcare system context [30]. As we move forward, efforts to reduce health disparities and improve the quality of life for individuals with chronic musculoskeletal pain should continue to be a priority.
Study limitations
While this pilot study aims to assess the feasibility of an online MBSR intervention for individuals with chronic musculoskeletal pain, some limitations should be acknowledged. Selection bias may arise due to the requirement for English proficiency and internet access, potentially excluding individuals from lower socioeconomic backgrounds. This limitation will be explicitly discussed in the study’s findings interpretation, and future research should explore strategies to enhance accessibility, such as translated materials and mobile-based adaptations. The small sample size limits generalisability, as pilot studies are not powered to detect definitive treatment effects. Differences in engagement between online and in-person MBSR programs may also impact adherence, as digital interventions often experience higher attrition rates [56]. To mitigate this, we will implement structured reminders, participant check-ins, and engagement tracking. Additionally, expectation-related bias may influence adherence, as participants’ perceptions of treatment effectiveness can shape engagement levels [57]. To address these challenges, both groups will receive clear information on the exploratory nature of the study and its contribution to chronic pain research. Despite these limitations, this study will generate valuable feasibility data to refine the intervention and inform a larger-scale trial.
Data availability
Data will be made available on reasonable request.
References
Woolf AD, Akesson KE. Musculoskeletal health – The case for action. Best Practice & Research Clinical Rheumatology. 2020;34(5):101627. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.berh.2020.101627.
Blyth FM, Briggs AM, Schneider CH, et al. The global burden of musculoskeletal pain—where to from here? American journal of public health. 2019;109(1):35–40.
Cieza A, Causey K, Kamenov K, et al. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2021;396(10267):2006–17. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S0140-6736(20)32340-0.
Australian Institute of Health and Welfare. Disease expenditure in Australia 2018-19, 2021. Retrieved from https://www.aihw.gov.au/reports/health-welfare-expenditure/disease-expenditure-australia.
Australian Institute of Health and Welfare. Australian Burden of Disease Study 2018 – Key findings. Canberra: AIHW, 2021
Babatunde OO, Jordan JL, Van der Windt DA, et al. Effective treatment options for musculoskeletal pain in primary care: A systematic overview of current evidence. PLoS One. 2017;12(6):e0178621. https://doiorg.publicaciones.saludcastillayleon.es/10.1371/journal.pone.0178621.
Meyer C, Denis CM, Berquin AD. Secondary prevention of chronic musculoskeletal pain: A systematic review of clinical trials. Annals of Physical and Rehabilitation Medicine. 2018;61(5):323–38. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.rehab.2018.03.002.
Blyth FM, Huckel Schneider C. Global burden of pain and global pain policy-creating a purposeful body of evidence. Pain. 2018;159(Suppl 1):S43–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/j.pain.0000000000001311.
Karos K, McParland JL, Bunzli S, et al. The social threats of COVID-19 for people with chronic pain. Pain. 2020;161(10):2229–35. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/j.pain.0000000000002004.
Vos T, Barber RM, Bell B, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The lancet. 2015;386(9995):743–800.
Gatchel RJ, Peng YB, Peters ML, et al. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull. 2007;133(4):581–624. https://doiorg.publicaciones.saludcastillayleon.es/10.1037/0033-2909.133.4.581.
Svanberg M, Stalnacke BM, Enthoven P, et al. Impact of emotional distress and pain-related fear on patients with chronic pain: Subgroup analysis of patients referred to multimodal rehabilitation. J Rehabil Med. 2017;49(4):354–61. https://doiorg.publicaciones.saludcastillayleon.es/10.2340/16501977-2212.
Kohrt BA, Griffith JL, Patel V. Chronic pain and mental health: integrated solutions for global problems. Pain. 2018;159(Suppl 1):S85–90. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/j.pain.0000000000001296.
Bushnell MC, Ceko M, Low LA. Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci. 2013;14(7):502–11. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/nrn3516.
Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082–97. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S0140-6736(21)00393-7.
National Pain Summit Initiative. National Pain Strategy: Pain management for all Australians. Painaustralia, 2011. Retrieved from https://www.painaustralia.org.au.
Hogg MN, Kavanagh A, Farrell MJ, et al. Waiting in Pain II: An Updated Review of the Provision of Persistent Pain Services in Australia. Pain Med. 2021;22(6):1367–75. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/pm/pnaa374.
Lynch ME, Campbell F, Clark AJ, et al. A systematic review of the effect of waiting for treatment for chronic pain. Pain. 2008;136(1–2):97–116. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.pain.2007.06.018.
Kabat-Zinn J, Hanh TN. Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness. Delta, 2009.
Kabat-Zinn J. Full catastrophe living, revised edition: how to cope with stress, pain and illness using mindfulness meditation. Hachette uK, 2013.
Hilton L, Hempel S, Ewing BA, et al. Mindfulness Meditation for Chronic Pain: Systematic Review and Meta-analysis. Ann Behav Med. 2017;51(2):199–213. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s12160-016-9844-2.
Anheyer D, Haller H, Barth J, et al. Mindfulness-Based Stress Reduction for Treating Low Back Pain: A Systematic Review and Meta-analysis. Ann Intern Med. 2017;166(11):799–807. https://doiorg.publicaciones.saludcastillayleon.es/10.7326/M16-1997.
Goyal M, Singh S, Sibinga EM, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med. 2014;174(3):357–68. https://doiorg.publicaciones.saludcastillayleon.es/10.1001/jamainternmed.2013.13018.
Cherkin DC, Sherman KJ, Balderson BH, et al. Effect of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care on Back Pain and Functional Limitations in Adults With Chronic Low Back Pain: A Randomized Clinical Trial. JAMA. 2016;315(12):1240–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1001/jama.2016.2323.
Toivonen KI, Zernicke K, Carlson LE. Web-Based Mindfulness Interventions for People With Physical Health Conditions: Systematic Review. J Med Internet Res. 2017;19(8):e303. https://doiorg.publicaciones.saludcastillayleon.es/10.2196/jmir.7487.
Krusche A, Cyhlarova E, Williams JM. Mindfulness online: an evaluation of the feasibility of a web-based mindfulness course for stress, anxiety and depression. BMJ Open. 2013;3(11):e003498. https://doiorg.publicaciones.saludcastillayleon.es/10.1136/bmjopen-2013-003498.
Morone NE. Not Just Mind Over Matter: Reviewing With Patients How Mindfulness Relieves Chronic Low Back Pain. J Evid Based Integr Med 2019;24:2515690X19838490. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/2515690X19838490 [published Online First: 2019/04/04]
Herman PM, Anderson ML, Sherman KJ, et al. Cost-effectiveness of Mindfulness-based Stress Reduction Versus Cognitive Behavioral Therapy or Usual Care Among Adults With Chronic Low Back Pain. Spine (Phila Pa 1976) 2017;42(20):1511-20. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/BRS.0000000000002344 [published Online First: 2017/07/26]
Demarzo MM, Cebolla A, Garcia-Campayo J. The implementation of mindfulness in healthcare systems: a theoretical analysis. Gen Hosp Psychiatry. 2015;37(2):166–71. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.genhosppsych.2014.11.013.
Pearson N, Naylor PJ, Ashe MC, et al. Guidance for conducting feasibility and pilot studies for implementation trials. Pilot Feasibility Stud. 2020;6(1):167. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40814-020-00634-w.
Institute S. Translational Research Framework. Testing innovation in policy, programes and service delivery. https://www.saxinstitute.org.au/wp-content/uploads/Translational-Research-Framework.pdf [
Fort DG, Herr TM, Shaw PL, et al. Mapping the evolving definitions of translational research. J Clin Transl Sci. 2017;1(1):60–6. https://doiorg.publicaciones.saludcastillayleon.es/10.1017/cts.2016.10.
Eldridge SM, Chan CL, Campbell MJ, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2016;2:64. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40814-016-0105-8.
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/intqhc/mzm042.
Nicholas M, Vlaeyen JWS, Rief W, et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;160(1):28–37. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/j.pain.0000000000001390.
Butler DS, Moseley GL. Explain Pain 2nd Edn. Noigroup publications; 2013.
Moseley GL, Butler DS. Fifteen years of explaining pain: the past, present, and future. The Journal of Pain. 2015;16(9):807–13.
Rebbeck T, Evans K, Ferreira P, et al. Implementation of a novel stratified PAthway of CarE for common musculoskeletal (MSK) conditions in primary care: protocol for a multicentre pragmatic randomised controlled trial (the PACE MSK trial). BMJ Open. 2021;11(12):e057705. https://doiorg.publicaciones.saludcastillayleon.es/10.1136/bmjopen-2021-057705.
Avery KN, Williamson PR, Gamble C, et al. Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ open. 2017;7(2):e013537.
Mellor K, Albury C, Dutton SJ, et al. Recommendations for progression criteria during external randomised pilot trial design, conduct, analysis and reporting. Pilot and Feasibility Studies. 2023;9(1):59.
Tardif H, Arnold C, Hayes C, et al. Establishment of the Australasian Electronic Persistent Pain Outcomes Collaboration. Pain Medicine. 2016;18(6):1007–18. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/pm/pnw201.
Tan G, Jensen MP, Thornby JI, et al. Validation of the Brief Pain Inventory for chronic nonmalignant pain. The Journal of Pain. 2004;5(2):133–7.
Nicholas MK. The pain self-efficacy questionnaire: taking pain into account. European journal of pain. 2007;11(2):153–63.
Sullivan MJ, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychological assessment. 1995;7(4):524.
Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): Construct validity and normative data in a large non-clinical sample. British journal of clinical psychology. 2005;44(2):227–39.
Wicksell RK, Olsson GL, Melin L. The Chronic Pain Acceptance Questionnaire (CPAQ)-further validation including a confirmatory factor analysis and a comparison with the Tampa Scale of Kinesiophobia. Eur J Pain. 2009;13(7):760–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ejpain.2008.09.003.
Hassed C, Flighty A, Chambers R, et al. Advancing the Assessment of Mindfulness-Based Meditation Practice: Psychometric Evaluation of the Mindfulness Adherence Questionnaire. Cognitive Therapy and Research. 2021;45(1):190–204. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s10608-020-10150-z.
Britton WB, Lindahl JR, Cooper DJ, et al. Defining and measuring meditation-related adverse effects in mindfulness-based programs. Clin Psychol Sci. 2021;9(6):1185–204. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/2167702621996340.
Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharmaceutical Statistics: The Journal of Applied Statistics in the Pharmaceutical Industry. 2005;4(4):287–91.
Cocks K, Torgerson DJ. Sample size calculations for pilot randomized trials: a confidence interval approach. Journal of clinical epidemiology. 2013;66(2):197–201.
Whitehead AL, Julious SA, Cooper CL, et al. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Statistical Methods in Medical Research. 2016;25(3):1057–73. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/0962280215588241.
Browne RH. On the use of a pilot sample for sample size determination. Statistics in medicine. 1995;14(17):1933–40.
Carpenter CM, Suto M. Qualitative research for occupational and physical therapists: A practical guide. Wiley, 2008.
Lee EC, Whitehead AL, Jacques RM, et al. The statistical interpretation of pilot trials: should significance thresholds be reconsidered? BMC Medical Research Methodology. 2014;14(1):41. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/1471-2288-14-41.
Braun V, Clarke V. "Thematic analysis: A practical guide." 2021: 1-100.
Eysenbach G. The law of attrition. Journal of medical Internet research. 2005;7(1):e402.
Boot WR, Simons DJ, Stothart C, et al. The pervasive problem with placebos in psychology: Why active control groups are not sufficient to rule out placebo effects. Perspectives on psychological science. 2013;8(4):445–54.
Acknowledgements
We want to acknowledge Dr Hong, a Pain Specialist from the Department of Anaesthesia at the CRGP, for supporting the study and facilitating recruitment at the CRGP. We also would like to acknowledge Mrs Rossi and Mrs Wilson, the Clinical Nurse Consultants at the RPAH and the CRGP, for supporting the study and facilitating recruitment at the RPAH and the CRGP, respectively. We acknowledge the importance of involving consumers in the co-design and delivery of our research. Therefore, we have involved a member of the RPAH Consumer and Community Advisory Network (Mrs McDonnell) in developing this pilot study. Mrs McDonnell has lived with chronic pain for many years. She has provided input during the research team meetings and feedback regarding our recruitment strategies and participant information sheets. We would also like to express our gratitude to Mrs Goddard and Openground for their invaluable contributions to the development and delivery of the mindfulness-based stress reduction program used in this study. Their expertise and commitment to mindfulness training have been instrumental in shaping the intervention.
Funding
This study is funded by a competitive Sydney Health Partners Implementation Science Grant. The funder has no part in designing or implementing the study or in the analysis, data interpretation or presentation of the results.
Author information
Authors and Affiliations
Contributions
All authors contributed to the design of the study. ABA is the Coordinating Principal Investigator. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This protocol was prospectively approved by the Human Research Ethics Committee from the Sydney Local Health District (Local HREC reference 2022/ETH00553). All participants must sign a consent form before entering the study.
Consent for publication
Not applicable.
Competing interests
The authors declare no conflicts of interest related to this study. However, ABA was invited to join the advisory board of Openground in 2025, well after the study had been fully funded, registered, and approved by the relevant ethics committees. This advisory role was extended post hoc and has no influence on the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
40814_2025_1612_MOESM1_ESM.doc
Supplementary Material 1. SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documents
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Amorim, A.B., Rebbeck, T., Van Dam, N.T. et al. The feasibility and acceptability of an online mindfulness-based stress reduction program for chronic musculoskeletal pain: protocol for a pilot randomised controlled trial. Pilot Feasibility Stud 11, 30 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40814-025-01612-w
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40814-025-01612-w